Zepbound (tirzepatide) is a dual GLP-1/GIP receptor agonist primarily approved for chronic weight management, and also for type 2 diabetes (as Mounjaro), working by enhancing insulin secretion, slowing gastric emptying, and reducing appetite
Antiemetic medications are generally not routinely recommended for GLP-1-associated nausea, as symptoms typically improve with time
Luego del primer mes, ya se suelen observar mejoras, aunque los especialistas indican que al tercer mes es cuando se puede evaluar su efectividad en cada paciente
The small intestine is normally a relatively hostile environment for bacteria
Whether youre just starting or already on your fitness journey, our coaches offer personalized, flexible advice to help you build lasting habits and achieve real results
Though its primarily used for blood sugar control in type 2 diabetes, it also provides cardiovascular and kidney benefits